# Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia

> **NCT00399074** · PHASE3 · COMPLETED · sponsor: **Makerere University** · enrollment: 220 (estimated)

## Conditions studied

- Sickle Cell Anemia
- Malaria

## Interventions

- **DRUG:** sulfadoxine pyrimethamine

## Key facts

- **NCT ID:** NCT00399074
- **Lead sponsor:** Makerere University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2009-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399074, "Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell Anemia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00399074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*